Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental validation of Davis LUT module with photonic crystals for GATE simulations.

Physics in medicine and biologyĀ·2026
Same author

Computational Fluid Dynamics Simulations to Inform Cancer Therapeutics.

Annual review of biomedical engineeringĀ·2026
Same author

Current Status of Cherenkov-Based Gamma Detectors for TOF-PET and Proton Range Verification.

IEEE transactions on radiation and plasma medical sciencesĀ·2026
Same author

Improving CTR with the FastIC ASIC for TOF-PET by overcoming SiPM noise with baseline correction.

IEEE transactions on radiation and plasma medical sciencesĀ·2026
Same author

Erratum to Xiao Y, Benedict S, Cui Y, Glide-Hurst C, Graves S, Jia X, KryF S, Li H, Lin L, Matuszak M, Newpower M, Paganetti H, Qi XS, Roncali E, Rong Y, Sgouros G, Simone 2nd CB, Sunderland JJ, Taylor PA, Tchelebi L, Weldon M, Zou JW, Wuthrick EJ, Machtay M, Le QT, Buchsbaum JC. Embracing the future of clinical trials in radiation therapy: an NRG oncology CIRO technology retreat whitepaper on pioneering technologies and AI-driven solutions. Int J of Radiat Oncol Biol Phys 2025:122;443-457.

International journal of radiation oncology, biology, physicsĀ·2026
Same author

Nuclear Medicine AI in Action: The Bethesda Report (AI Summit 2024).

Journal of nuclear medicine : official publication, Society of Nuclear MedicineĀ·2025

Related Experiment Video

Updated: Jan 15, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.7K

Toward Digital Twins for Optimal Radioembolization.

Nisanth Kumar Panneerselvam1, Guneet Mummaneni1, Emilie Roncali2

  • 1Department of Biomedical Engineering, University of California Davis, Davis, CA, USA.

PET Clinics
|October 15, 2025
PubMed
Summary

Digital twins using computational fluid dynamics and AI can personalize liver radioembolization. This approach enhances treatment precision by modeling complex blood flow and microsphere delivery for better patient outcomes.

Keywords:
CFDComputational fluid dynamicsDigital twinsGANsGenerative AIInterventional radiologyPINNsRadioembolization

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.8K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.2K

Related Experiment Videos

Last Updated: Jan 15, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.7K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.8K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.2K

Area of Science:

  • Hepatobiliary Medicine
  • Medical Imaging & Simulation
  • Interventional Oncology

Background:

  • Radioembolization is a liver cancer treatment using radioactive microspheres delivered via the hepatic artery.
  • Treatment effectiveness is influenced by complex hepatic artery anatomy, blood flow dynamics, and microsphere behavior.
  • Optimizing treatment delivery requires advanced methods to account for patient-specific variations.

Purpose of the Study:

  • To review the application of computational fluid dynamics (CFD) and generative artificial intelligence (AI) in radioembolization.
  • To highlight the role of physics-informed neural networks in creating patient-specific digital twins.
  • To discuss the potential of digital twins for enhancing personalized and precise radioembolization treatment planning.

Main Methods:

  • Review of core principles in computational fluid dynamics (CFD) for simulating blood flow.
  • Discussion of generative artificial intelligence (AI) techniques, particularly physics-informed neural networks.
  • Exploration of digital twin technology for patient-specific modeling in medical applications.

Main Results:

  • CFD and AI-powered digital twins offer a promising approach to model complex hepatic arterial anatomy and blood flow.
  • Physics-informed AI can integrate physiological data to create accurate patient-specific simulations.
  • These digital twins can predict microsphere transport and deposition, aiding treatment planning.

Conclusions:

  • Patient-specific digital twins integrating CFD and AI represent a significant advancement in radioembolization planning.
  • This technology facilitates enhanced personalization and precision in microsphere delivery.
  • The translation of digital twins into clinical practice holds potential for improved liver cancer treatment outcomes.